Companies Market Stem Cell Treatments to Long COVID Patients
Prices are high but evidence is scant that therapies work, researchers say
Source: medpagetoday.com
Stay updated with breaking news from Barlett Steele. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Prices are high but evidence is scant that therapies work, researchers say
Here's what it is, what it isn't, and what separates it from a true diagnosis
A weekly roundup of healthcare's encounters with the courts
Tennessee court rejects former nurse's appeal to overturn nursing board's 2021 decision
UnitedHealth's Optum division added 20,000 doctors this year alone